This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovations of Craig Antony Joseph Laferriere
Introduction
Craig Antony Joseph Laferriere is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of vaccines, particularly focusing on bacterial polysaccharide antigen vaccines. His work is essential in advancing medical science and improving public health.
Latest Patents
Laferriere holds 1 patent related to his innovative work. His patent involves bacterial polysaccharides conjugated to protein D, which plays a crucial role in the development of effective vaccines. This invention is a testament to his dedication to enhancing vaccine technology.
Career Highlights
Laferriere is associated with GlaxoSmithKline Biologicals SA, a leading company in the pharmaceutical industry. His role at the company has allowed him to work on groundbreaking research and development projects that aim to improve vaccine efficacy and safety.
Collaborations
Throughout his career, Laferriere has collaborated with esteemed colleagues, including Carine Capiau and Pierre Michel Desmons. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Craig Antony Joseph Laferriere's contributions to vaccine development highlight his commitment to advancing medical science. His innovative work continues to impact the field positively, paving the way for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile